BCDA ▼ -1.9% - BioCardia, Inc. $BCDA - BioCardia Confirms Timing and Provides Update on FDA Helix Pre-Submission and PMDA CardiAMP HF Shonin Submission BioCardia shares fell 1.9% today following the company's confirmation of timing for its FDA Helix pre-submission meeting and an update on its PMDA CardiAMP HF Shonin submission in Japan. The stock's decline suggests investors may have viewed the regulatory timeline or submission details as less favorable than anticipated. 23-SEP-2026 09:15 AM ET